Adamczyk-Sowa M - Search Results

1

Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis.

Niedziela N, Nowak-Kiczmer M, Malciene L, Stasiołek M, Niedziela JT, Czuba ZP, Lis M, Sowa A, Adamczyk-Sowa M. Niedziela N, et al. Among authors: adamczyk sowa m. Int J Mol Sci. 2024 Sep 29;25(19):10502. doi: 10.3390/ijms251910502. Int J Mol Sci. 2024. PMID: 39408830 Free PMC article.

2

[Stroke as the first manifestation of atrial fibrillation].

Warmus P, Adamczyk-Sowa M. Warmus P, et al. Wiad Lek. 2018;71(9):1829-1834. Wiad Lek. 2018. PMID: 30737948 Polish.

3

Diagnostics of sporadic creutzfeldt-jakob disease – literature review.

Ciepierski WM, Adamczyk-Sowa M, Męcik Kronenberg T, Wierzcbicki K. Ciepierski WM, et al. Wiad Lek. 2019 Oct 31;72(10):1995-2004. Wiad Lek. 2019. PMID: 31982612 Review.

4

Epidemiology and clinical record of multiple sclerosis in selected countries: a systematic review.

Niedziela N, Adamczyk-Sowa M, Pierzchała K. Niedziela N, et al. Int J Neurosci. 2014 May;124(5):322-30. doi: 10.3109/00207454.2013.840618. Epub 2013 Oct 4. Int J Neurosci. 2014. PMID: 23998938 Review.

5

Oxidative modification of serum proteins in multiple sclerosis.

Sadowska-Bartosz I, Adamczyk-Sowa M, Galiniak S, Mucha S, Pierzchala K, Bartosz G. Sadowska-Bartosz I, et al. Neurochem Int. 2013 Nov;63(5):507-16. doi: 10.1016/j.neuint.2013.08.009. Epub 2013 Sep 12. Neurochem Int. 2013. PMID: 24036284

6

Demographic characteristics of MS patients in Poland's upper Silesia region.

Pierzchala K, Adamczyk-Sowa M, Dobrakowski P, Kubicka-Baczyk K, Niedziela N, Sowa P. Pierzchala K, et al. Int J Neurosci. 2015 May;125(5):344-51. doi: 10.3109/00207454.2014.937002. Epub 2014 Jul 11. Int J Neurosci. 2015. PMID: 24946203

7

Calcium-phosphate metabolism in patients with multiple sclerosis.

Kubicka-Baczyk K, Labuz-Roszak B, Pierzchala K, Adamczyk-Sowa M, Machowska-Majchrzak A. Kubicka-Baczyk K, et al. J Endocrinol Invest. 2015 Jun;38(6):635-42. doi: 10.1007/s40618-014-0235-x. Epub 2015 Jan 18. J Endocrinol Invest. 2015. PMID: 25596662 Free PMC article.

8

Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.

Adamczyk-Sowa M, Sowa P, Adamczyk J, Niedziela N, Misiolek H, Owczarek M, Zwirska-Korczala K. Adamczyk-Sowa M, et al. J Physiol Pharmacol. 2016 Apr;67(2):235-42. J Physiol Pharmacol. 2016. PMID: 27226183 Free article. Clinical Trial.

9

Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.

Adamczyk-Sowa M, Sowa P, Mucha S, Zostawa J, Mazur B, Owczarek M, Pierzchała K. Adamczyk-Sowa M, et al. Med Sci Monit. 2016 Jul 15;22:2484-91. doi: 10.12659/msm.895702. Med Sci Monit. 2016. PMID: 27420299 Free PMC article.

10

Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches.

Niedziela N, Adamczyk-Sowa M, Niedziela JT, Mazur B, Kluczewska E, Sowa P, Gąsior M. Niedziela N, et al. Biomed Res Int. 2016;2016:4570351. doi: 10.1155/2016/4570351. Epub 2016 Dec 19. Biomed Res Int. 2016. PMID: 28078290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters